ethidium bromide has been researched along with camptothecin in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 18 (85.71) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Hranjec, M; Karminski-Zamola, G; Kralj, M; Pavelić, K; Piantanida, I; Suman, L | 1 |
| Dong, G; Guo, Z; Miao, Z; Sheng, C; Wang, S; Yao, J; Zhang, W; Zhang, Y | 1 |
| Banerjee, UC; Baviskar, AT; Das, D; Guchhait, SK; Kandekar, S; Kashyap, M; Kundu, CN; Mohapatra, P; Preet, R; Satapathy, SR; Siddharth, S | 1 |
| Chang, IH; Jun, KY; Kwon, Y; Lee, E; Lee, ES; Na, Y; Park, SE | 1 |
| Chen, SB; Gu, LQ; Huang, SL; Huang, ZS; Li, D; Mai, YW; Ou, TM; Tan, JH; Wang, HG; Xie, HT; Yao, BL; Yao, PF | 1 |
| Amrutkar, S; Banerjee, UC; Guchhait, SK; Kundu, CN; Nayak, A; Priyadarshani, G | 1 |
| Chang, YQ; Chen, WM; Hou, W; Jiang, RW; Lin, H; Lin, J; Liu, X; Peng, CK; Sun, PH; Wang, ZY; Xu, J | 1 |
| Chang, YQ; Chen, WM; Hou, W; Lin, H; Lin, J; Lu, K; Peng, CK; Sun, PH; Xu, XJ; Zeng, T | 1 |
| Dong, G; Fang, Y; Liu, N; Liu, Y; Sheng, C; Wu, S; Zhang, W | 1 |
| Ajitha, A; Akunuri, R; Kamal, A; Kovvuri, J; Nagaraju, B; Nagesh, N; Nayak, VL; Rao, MPN | 1 |
| Chowdhury, SR; Dhatchana Moorthy, N; Ganesan, K; Gunasekaran, K; Iqbal, S; Mageshwaran, T; Majumder, HK; Mohanakrishnan, AK; Muthu Ramalingam, B; Rajesh, BN; Saha, S; Siva, R; Vellaichamy, E | 1 |
| Chen, HX; Dong, CZ; Du, ZY; Huang, ZS; Jiang, H; Li, PH; Li, YL; Tang, YD; Zhang, LY; Zhang, WJ; Zhao, MC; Zhou, W | 1 |
| Chen, HX; Dong, CZ; Du, ZY; Jiang, H; Li, PH; Wang, J; Zhang, K; Zhang, WJ | 1 |
| An, LK; Chen, JW; Gu, LQ; Huang, ZS; Yang, H; Yu, LM; Yu, Q; Zhu, TW | 1 |
| Banwell, MG; Chen, WM; Hou, W; Lin, H; Lin, J; Sun, PH; Wang, ZY; Zeng, T | 1 |
| Chen, H; Dong, C; Du, Z; Jiang, H; Li, P; Li, Y; Zhang, K; Zhang, W | 1 |
| Agama, K; An, LK; Hu, DX; Kiselev, E; Marchand, C; Ofori-Atta, K; Pommier, Y; Ravji, A; Tang, WL; Wang, HW; Yang, H; Zhang, XR; Zhang, Y | 1 |
| An, LK; Hao, XJ; Jin, LY; Khan, A; Liu, H; Liu, HY; Qin, XJ; Yan, H; Yu, Q | 1 |
| Chen, NY; Mo, DL; Pan, CX; Su, GF; Wei, K; Wei, XW; Yuan, JM; Zhang, GH | 1 |
| Che, T; Hu, DX; Li, D; Shu, B; Yu, Q; Zhang, SS | 1 |
| Chen, S; Li, M; Meng, C; Wang, Y; Yin, X; Yuan, C | 1 |
21 other study(ies) available for ethidium bromide and camptothecin
| Article | Year |
|---|---|
Novel amidino-substituted thienyl- and furylvinylbenzimidazole: derivatives and their photochemical conversion into corresponding diazacyclopenta[c]fluorenes. synthesis, interactions with DNA and RNA, and antitumor evaluation. 4.
Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; Circular Dichroism; DNA; DNA Topoisomerases, Type I; Fluorenes; Humans; Nucleic Acid Denaturation; Photochemistry; RNA; Spectrophotometry, Ultraviolet | 2008 |
New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure-activity relationship analysis and biological evaluations.
Topics: Antineoplastic Agents, Phytogenic; Biological Products; Cell Line, Tumor; Drug Screening Assays, Antitumor; Evodia; Humans; Quinazolines; Structure-Activity Relationship | 2012 |
Indenoindolone derivatives as topoisomerase II-inhibiting anticancer agents.
Topics: Antineoplastic Agents; DNA Topoisomerases, Type II; Humans; Indoles; Models, Molecular; Neoplasms; Topoisomerase II Inhibitors | 2013 |
3-(3-Butylamino-2-hydroxy-propoxy)-1-hydroxy-xanthen-9-one acts as a topoisomerase IIα catalytic inhibitor with low DNA damage.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Biocatalysis; Cell Line, Tumor; Cell Proliferation; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Structure-Activity Relationship; Topoisomerase II Inhibitors; Xanthones | 2013 |
Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.
Topics: Amines; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; HeLa Cells; HL-60 Cells; Humans; K562 Cells; Molecular Structure; Phenazines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2015 |
Scaffold-hopping of bioactive flavonoids: Discovery of aryl-pyridopyrimidinones as potent anticancer agents that inhibit catalytic role of topoisomerase IIα.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Design; Flavonoids; Humans; Neoplasm Invasiveness; Pyrimidinones; Topoisomerase II Inhibitors | 2016 |
Novel securinine derivatives as topoisomerase I based antitumor agents.
Topics: Antineoplastic Agents; Azepines; Cell Line, Tumor; Cell Proliferation; DNA Cleavage; DNA Topoisomerases, Type I; Drug Design; Heterocyclic Compounds, Bridged-Ring; Humans; Lactones; Models, Molecular; Piperidines; Protein Conformation; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2016 |
Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA Cleavage; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Design; Furans; Humans; Molecular Docking Simulation; Nucleic Acid Conformation; Protein Conformation; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2017 |
Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.
Topics: Anthraquinones; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; Drug Design; Humans; Molecular Docking Simulation; Neoplasms; Thiadiazoles; Topoisomerase I Inhibitors | 2017 |
Design, synthesis and biological evaluation of new β-carboline-bisindole compounds as DNA binding, photocleavage agents and topoisomerase I inhibitors.
Topics: Antineoplastic Agents; Binding Sites; Carbolines; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Indoles; Molecular Docking Simulation; Molecular Structure; Photosensitizing Agents; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2018 |
Synthesis and Biological Evaluation of Calothrixins B and their Deoxygenated Analogues.
Topics: Carbazoles; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; DNA Damage; DNA Topoisomerases, Type II; Drug Evaluation, Preclinical; Humans; Indole Alkaloids; Models, Molecular; Nucleic Acid Conformation; Oxygen; Topoisomerase II Inhibitors | 2018 |
Synthesis of carbazole derivatives containing chalcone analogs as non-intercalative topoisomerase II catalytic inhibitors and apoptosis inducers.
Topics: Antineoplastic Agents; Apoptosis; Biocatalysis; Carbazoles; Cell Cycle Checkpoints; Cell Proliferation; Chalcone; DNA Cleavage; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Molecular Structure; Plasmids; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2018 |
Synthesis and biological evaluation of novel carbazole-rhodanine conjugates as topoisomerase II inhibitors.
Topics: Antineoplastic Agents; Carbazoles; Cell Line, Tumor; DNA Topoisomerases, Type II; Drug Screening Assays, Antitumor; Etoposide; Humans; Intercalating Agents; Rhodanine; Topoisomerase II Inhibitors | 2018 |
Synthesis, cytotoxicity and structure-activity relationship of indolizinoquinolinedione derivatives as DNA topoisomerase IB catalytic inhibitors.
Topics: Antineoplastic Agents; Biocatalysis; Cell Proliferation; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indolizines; Molecular Structure; Quinolones; Structure-Activity Relationship; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 2018 |
Novel bivalent securinine mimetics as topoisomerase I inhibitors.
Topics: | 2017 |
Design, synthesis and biological evaluation of benzimidazole-rhodanine conjugates as potent topoisomerase II inhibitors.
Topics: | 2018 |
Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; DNA Cleavage; DNA Topoisomerases, Type I; Drug Design; Humans; Models, Molecular; Phenanthridines; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Protein Conformation; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2018 |
Eucalypglobulusals A-J, Formyl-Phloroglucinol-Terpene Meroterpenoids from Eucalyptus globulus Fruits.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; DNA Topoisomerases, Type I; Drug Screening Assays, Antitumor; Eucalyptus; Fruit; Humans; Molecular Structure; Terpenes; Topoisomerase I Inhibitors | 2018 |
Cryptolepine and aromathecin based mimics as potent G-quadruplex-binding, DNA-cleavage and anticancer agents: Design, synthesis and DNA targeting-induced apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Breaks, Double-Stranded; DNA Cleavage; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; G-Quadruplexes; Heterocyclic Compounds, 4 or More Rings; Humans; Indole Alkaloids; Mice; Molecular Structure; Neoplasms, Experimental; Quinolines; Structure-Activity Relationship | 2019 |
Synthesis and biological evaluation of novel indole-pyrazoline hybrid derivatives as potential topoisomerase 1 inhibitors.
Topics: Binding Sites; DNA Topoisomerases, Type I; DNA, Superhelical; Drug Design; Humans; Indoles; Molecular Dynamics Simulation; Pyrazoles; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2020 |
Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L.
Topics: Alkaloids; Azocines; Molecular Docking Simulation; Quinolizines; Seeds; Sophora | 2022 |